Vemurafenib (PLX-4032)-induced keratoses: verrucous but not verrucae

J Am Acad Dermatol. 2013 Aug;69(2):e95-6. doi: 10.1016/j.jaad.2012.03.027.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy, Needle
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Keratosis / chemically induced*
  • Keratosis / pathology
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Middle Aged
  • Neoplasm Metastasis
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Risk Assessment
  • Skin Diseases / drug therapy
  • Skin Diseases / pathology
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Vemurafenib
  • Warts / chemically induced*
  • Warts / pathology

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Proto-Oncogene Proteins B-raf